4/14
06:59 am
coll
2 Reasons to Watch COLL and 1 to Stay Cautious [Yahoo! Finance]
Medium
Report
2 Reasons to Watch COLL and 1 to Stay Cautious [Yahoo! Finance]
4/11
10:07 pm
coll
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
4/9
08:58 am
coll
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $46.00 price target on the stock.
Medium
Report
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $46.00 price target on the stock.
4/2
08:12 pm
coll
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 30% ROE Better Than Average? [Yahoo! Finance]
Medium
Report
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 30% ROE Better Than Average? [Yahoo! Finance]
4/2
08:06 am
coll
A Look Back at Branded Pharmaceuticals Stocks' Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack [Yahoo! Finance]
Low
Report
A Look Back at Branded Pharmaceuticals Stocks' Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack [Yahoo! Finance]
4/1
08:13 am
coll
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
Low
Report
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
4/1
08:00 am
coll
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference
Low
Report
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference
3/27
08:00 am
coll
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting
Medium
Report
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting
3/24
08:09 am
coll
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Low
Report
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
3/17
08:08 am
coll
Collegium Pharmaceutical chairman of the board to retire [Seeking Alpha]
Low
Report
Collegium Pharmaceutical chairman of the board to retire [Seeking Alpha]
3/17
07:07 am
coll
Collegium Announces Updates to its Board of Directors and Executive Leadership Team [Yahoo! Finance]
Low
Report
Collegium Announces Updates to its Board of Directors and Executive Leadership Team [Yahoo! Finance]
3/17
07:00 am
coll
Collegium Announces Updates to its Board of Directors and Executive Leadership Team
Low
Report
Collegium Announces Updates to its Board of Directors and Executive Leadership Team
3/10
06:57 pm
coll
Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care
Low
Report
Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care
3/4
08:00 am
coll
Collegium to Participate in Upcoming Investor Conferences
Low
Report
Collegium to Participate in Upcoming Investor Conferences
3/2
06:12 am
coll
Should You Be Adding Collegium Pharmaceutical (NASDAQ:COLL) To Your Watchlist Today? [Yahoo! Finance]
Low
Report
Should You Be Adding Collegium Pharmaceutical (NASDAQ:COLL) To Your Watchlist Today? [Yahoo! Finance]
3/1
07:07 pm
coll
Collegium Pharmaceutical Full Year 2024 Earnings: In Line With Expectations [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical Full Year 2024 Earnings: In Line With Expectations [Yahoo! Finance]
2/27
05:49 pm
coll
Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results [Yahoo! Finance]
Medium
Report
Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results [Yahoo! Finance]
2/27
04:50 pm
coll
Collegium Pharmaceutical's (NASDAQ:COLL) Q4 Sales Top Estimates, Stock Jumps 14.1% [Yahoo! Finance]
Medium
Report
Collegium Pharmaceutical's (NASDAQ:COLL) Q4 Sales Top Estimates, Stock Jumps 14.1% [Yahoo! Finance]
2/27
04:01 pm
coll
Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results
Medium
Report
Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results
2/27
02:32 am
coll
Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer [Yahoo! Finance]
Low
Report
Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer [Yahoo! Finance]
2/13
09:40 am
coll
Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025 [Yahoo! Finance]
Low
Report
Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025 [Yahoo! Finance]
2/13
08:00 am
coll
Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025
Low
Report
Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025
2/5
08:00 am
coll
Collegium Appoints Nancy S. Lurker to its Board of Directors
High
Report
Collegium Appoints Nancy S. Lurker to its Board of Directors
2/4
08:28 am
coll
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) had its price target lowered by analysts at Piper Sandler from $37.00 to $36.00. They now have a "neutral" rating on the stock.
Low
Report
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) had its price target lowered by analysts at Piper Sandler from $37.00 to $36.00. They now have a "neutral" rating on the stock.